Lantheus (LNTH)
(Delayed Data from NSDQ)
$81.83 USD
+1.31 (1.63%)
Updated May 31, 2024 04:00 PM ET
After-Market: $81.87 +0.04 (0.05%) 7:58 PM ET
1-Strong Buy of 5 1
B Value B Growth F Momentum B VGM
Price, Consensus and EPS Surprise
LNTH 81.83 +1.31(1.63%)
Will LNTH be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for LNTH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for LNTH
Lantheus Holdings (LNTH) Upgraded to Strong Buy: What Does It Mean for the Stock?
Best Momentum Stocks to Buy for May 31st
LNTH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Tenet Healthcare (THC) Gains 89% in a Year: More Room to Run?
Here's Why You Should Add Lantheus (LNTH) to Your Portfolio Now
Centene (CNC) Expands CHS Network, Shifts AcariaHealth Facility
Other News for LNTH
Director Heinz Maeusli Sells 18,373 Shares of Lantheus Holdings Inc (LNTH)
Insider Selling: Director Julie Mchugh Sells Shares of Lantheus Holdings Inc (LNTH)
Lantheus to Present at the William Blair 44th Annual Growth Stock Conference
Perspective Therapeutics: An Elevated Theranostics Play Flying Under Your Radar
Wall Street Analysts Are Bullish on Top Healthcare Picks